EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PRKACB Attenuates Chondrocyte Loss and Inflammation in Osteoarthritis

Weidan Xiao, Zhengmao Liu, Qijuan Zhang iD

Immunity, Inflammation and Disease · 2026-02 · 14 (2)

DOI: 10.1002/iid3.70342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 12.02.2026. Verfasst von Weidan Xiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Bone Disease Clinic, The Affiliated Hospital of Wuhan Sports University, Wuhan, Hubei Province, China. Hauptthemen laut MEDLINE: Chondrocytes, Osteoarthritis, Inflammation, Cyclic AMP-Dependent Protein Kinase Catalytic Subunits. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shizhen Talent Program of Hubei Province for Scientific Researc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous work revealed that protein kinase cAMP‐dependent catalytic β (PRKACB) may play a crucial role in osteoarthritis (OA) development. However, the mechanism by which PRKACB plays a role in OA still needs to be further investigated. Our aim was to explore the mechanism of PRKACB in a human chondrocyte inflammatory injury model.

Methods

Human CHON‐001 chondrocytes were treated with 10 ng/mL IL‐1β for 12 h to establish an in vitro model of chondrocyte inflammatory injury. Cell viability was determined by 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT) assay. Flow cytometry (FCM) was conducted to assess apoptosis. Western blot assays were carried out to measure cleaved caspase‐3, caspase‐3, PRKACB, collagen II, aggrecan, phosphorated protein kinase A (p‐PKA), PKA, cAMP response element‐binding protein (CREB) and p‐CREB protein expression levels. Reverse transcription quantitative polymerase chain reaction (RT‐qPCR) assay was used to measure PRKACB gene expression. Interleukin 6 (IL‐6), IL‐1β, and tumor necrosis factor alpha (TNF‐α) levels were measured by enzyme‐linked immunosorbent assay (ELISA).

Results

PRKACB expression was decreased in IL‐1β‐treated CHON‐001 cells. Transfection of a PRKACB plasmid increased PRKACB expression in CHON‐001 cells. IL‐1β significantly inhibited CHON‐001 cell viability; induced apoptosis; increased cleaved caspase‐3 expression and the cleaved caspase‐3/caspase‐3 ratio; promoted TNF‐α, IL‐6 and IL‐8 secretion; and decreased the expression levels of collagen II and aggrecan. However, these effects could be suppressed by the PRKACB plasmid. Moreover, we also found that PRKACB activated the PKA/CREB signaling pathway. H89 (a PKA inhibitor) distinctly reversed the effect of PRKACB on IL‐1β‐induced CHON‐001 cells.

Conclusion

PRKACB can increase cell viability and reduce inflammation by activating the PKA/CREB signaling pathway, and PRKACB is a novel target for OA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChondrocytesOsteoarthritisInflammationCyclic AMP-Dependent Protein Kinase Catalytic SubunitsHumansApoptosisInterleukin-1betaCell SurvivalCyclic AMP Response Element-Binding ProteinSignal TransductionCell LineCyclic AMP-Dependent Protein Kinases

Stichwörter der Autor:innen

CHON‐001 cellsPRKACBapoptosisinflammationosteoarthritis

Substanzen

Interleukin-1betaCyclic AMP-Dependent Protein Kinase Catalytic SubunitsPRKACB protein, humanCyclic AMP Response Element-Binding ProteinCyclic AMP-Dependent Protein Kinases

Autor:innen und Institutionen

  • Metabolic Bone Disease Clinic, The Affiliated Hospital of Wuhan Sports University, Wuhan, Hubei Province, China.
  • Department of Rehabilitation Medicine, The Affiliated Hospital of Wuhan Sports University, Wuhan, Hubei Province, China.

ORCID-Profile: Qijuan Zhang

Förderung

  • Shizhen Talent Program of Hubei Province for Scientific Researc

Zitieren

APA

Xiao, W., Liu, Z., & Zhang, Q. (2026). PRKACB Attenuates Chondrocyte Loss and Inflammation in Osteoarthritis. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70342

Vancouver

Xiao W, Liu Z, Zhang Q. PRKACB Attenuates Chondrocyte Loss and Inflammation in Osteoarthritis. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70342

BibTeX
@article{Xiao2026,
  author = {Xiao, Weidan and Liu, Zhengmao and Zhang, Qijuan},
  title = {PRKACB Attenuates Chondrocyte Loss and Inflammation in Osteoarthritis},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {2},
  doi = {10.1002/iid3.70342}
}
Kostenlos starten →